We are live on
!
Find out more
CAM
Claret Asset Management Portfolio holdings
AUM
$928M
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+12.89%
1 Year Est. Return
+25.4%
3 Year Est. Return
+73.27%
5 Year Est. Return
+90.16%
10 Year Est. Return
–
AUM
$507M
AUM Growth
+$53.8M
(+12%)
Cap. Flow
+$4.66M
Cap. Flow
% of AUM
0.92%
Top 10 Holdings %
Top 10 Hldgs %
48%
Holding
160
New
12
Increased
26
Reduced
91
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$3.57M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$1.99M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$1.75M |
| 4 |
Citigroup
C
|
+$1.58M |
| 5 |
Oaktree Specialty Lending
OCSL
|
+$1.06M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARAP
Paramount Global 5.75% Series A Mandatory Convertible Preferred Stock
PARAP
|
+$1.05M |
| 2 |
AbbVie
ABBV
|
+$325K |
| 3 |
NOA
North American Construction
NOA
|
+$310K |
| 4 |
QIPT
Quipt Home Medical
QIPT
|
+$306K |
| 5 |
DENN
Denny's
DENN
|
+$293K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.5% |
| 2 | Healthcare | 20.49% |
| 3 | Financials | 11.76% |
| 4 | Communication Services | 10.77% |
| 5 | Consumer Discretionary | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Cigna
CI
$72.7B
| – | – |
-636
| Closed | -$211K |
|
152
Invesco DB Agriculture Fund
DBA
$1.22B
| – | – |
-10,415
| Closed | -$210K |
|
153
Gilead Sciences
GILD
$162B
| – | – |
-2,403
| Closed | -$206K |
|
|
RDHL
154
Redhill Biopharma
RDHL
$3.53M
| – | – |
-228
| Closed | -$32K |
|
155
UnitedHealth
UNH
$367B
| – | – |
-408
| Closed | -$216K |
|
|
PARAP
156
DELISTED
Paramount Global 5.75% Series A Mandatory Convertible Preferred Stock
PARAP
| – | – |
-42,551
| Closed | -$1.05M |
|
Similar funds
WC
BCC
GP
ICM
TC
CFA
FPI
MHIC
Claret Asset Management's Q1 2023 Portfolio in Review
As of Q1 2023, Claret Asset Management held 160 positions worth $507M, up 12% from $453M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Claret Asset Management's Q1 2023 filing shows 12 new, 26 increased, 91 reduced and 7 closed positions. Its largest new stake was Somnigroup International: 5,625 shares worth $222K. The largest sale was Paramount Global 5.75% Series A Mandatory Convertible Preferred Stock, an estimated $1.05M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Claret Asset Management's largest Q1 2023 buy was Somnigroup International: 5,625 shares worth $222K.
- Claret Asset Management added most to CVS Health in Q1 2023, an estimated $3.57M increase.
- Claret Asset Management's biggest Q1 2023 reduction was AbbVie, cutting an estimated $325K.
- Claret Asset Management fully exited Paramount Global 5.75% Series A Mandatory Convertible Preferred Stock in Q1 2023, selling an estimated $1.05M.
- Claret Asset Management's ten largest holdings make up 48% of its $507M portfolio in Q1 2023.
- Claret Asset Management opened 12 new positions and closed 7 in Q1 2023.
- Claret Asset Management's portfolio value rose 12% quarter-over-quarter to $507M.
Based on Claret Asset Management's 13F filing for Q1 2023, filed 18 Apr 2023.